2seventy bio

2seventy bio is a company dedicated to outmaneuvering cancer and providing more time for patients. Inspired by the maximum speed of translating human thought into action, the company focuses on scientific expertise in gene therapy and oncology. It was spun out of bluebird bio, Inc., and has a heritage rooted in deep care for patients, thought leadership, and scientific innovation. The company collaborates with Bristol Myers Squibb and other industry partners, and is committed to promoting health equity and access to care. Its mission is to deliver more time to people living with multiple myeloma through innovative therapies, primarily focusing on the drug Abecma.